Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 6Tumor-Agnostic 4Genitourinary 4CNS 3Lymphoid 2Breast 2Plasma cell 1Other hematologic neoplasm 1Other 1Gynecologic 1Dermatologic 1

Conditions

Lymphoma 2Leukemia 1Breast Neoplasms 1

Interventions

Cyclophosphamide 342Rituximab 304Vincristine 157Doxorubicin 154venetoclax 153fludarabine 153Specimen Handling 152Prednisone 150Biopsy 122Magnetic Resonance Spectroscopy 117obinutuzumab 116Lenalidomide 109Dexamethasone 104Cytarabine 97ibrutinib 95Etoposide 92fludarabine phosphate 87Methotrexate 84acalabrutinib 78Bendamustine Hydrochloride 72zanubrutinib 71blinatumomab 63pembrolizumab 62CT-P10 60Gemcitabine 51Nivolumab 45glofitamab 44Calcium Dobesilate 44Mercaptopurine 43prednylidene 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Tests × Lymphoid × 1 year × Clear all
NCT04053439 2025-07-08

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Sunnybrook Health Sciences Centre

Recruiting
188 enrolled
Lymphoid

Lymphoma

NCT04541212 2025-06-15

CarChem

Montreal Heart Institute

Active not recruiting
169 enrolled
BreastLymphoidOther hematologic neoplasm

Breast Neoplasms, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡